Evidence map›Paper›PMID 9811641›Full record

ArticleJournal of bacteriology1998

atp Mutants of Escherichia coli fail to grow on succinate due to a transport deficiency.

F C Boogerd, L Boe, O Michelsen, P R Jensen

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Aerobicity stimulon iniScience · 2026
    Article
  3. Article
  4. Transcriptional and Metabolic Response of a Strain ofBiotech (Basel (Switzerland)) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. ATP synthase is necessary for microcin H47 antibiotic action.Antimicrobial agents and chemotherapy · 2001
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

F C BoogerdDepartment of Molecular Cell Physiology, Faculty of Biology, Free University, Amsterdam, The Netherlands.
L Boe
O Michelsen
P R Jensen
Technical University of Denmark · DKUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli atp mutants, which lack a functional H+-ATPase complex, are capable of growth on glucose but not on succinate or other C4-dicarboxylates (Suc- phenotype). Suc+ revertants of an atp deletion strain were isolated which were capable of growth on succinate even though they lack the entire H+-ATPase complex. Complementation in trans with the yhiF gene suppressed the growth of the Suc+ mutants on succinate, which implicates the yhiF gene product in the regulation of C4-dicarboxylate metabolism. Indeed, when the E. coli C4-dicarboxylate transporter (encoded by the dctA gene) was expressed in trans, the Suc- phenotype of the atp deletion strain reverted to Suc+, which shows that the reason why the E. coli atp mutant is unable to grow aerobically on C4-dicarboxylates is insufficient transport capacity for these substrates.

Indexed as

Bacterial ProteinsDicarboxylic Acid TransportersBiological TransportCarrier ProteinsChromosome MappingCulture MediaEscherichia coliGene DeletionGenetic Complementation TestMutagenesisPhenotypeProton-Translocating ATPasesSuccinatesTransposasesBacterial ProteinsCarrier ProteinsCulture MediadctA protein, Sinorhizobium melilotiDicarboxylic Acid TransportersProton-Translocating ATPasesSuccinatesTransposases

Identifiers

PMID9811641
PMCPMC107657
OpenAlexW1896713748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.